Your browser doesn't support javascript.
loading
Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide.
Delforge, Michel; Minuk, Leonard; Eisenmann, Jean-Claude; Arnulf, Bertrand; Canepa, Letizia; Fragasso, Alberto; Leyvraz, Serge; Langer, Christian; Ezaydi, Yousef; Vogl, Dan T; Giraldo-Castellano, Pilar; Yoon, Sung-Soo; Zarnitsky, Charles; Escoffre-Barbe, Martine; Lemieux, Bernard; Song, Kevin; Bahlis, Nizar Jacques; Guo, Shien; Monzini, Mara Silva; Ervin-Haynes, Annette; Houck, Vanessa; Facon, Thierry.
  • Delforge M; Universitair Ziekenhuis Leuven, Campus Gasthuisberg, Leuven, Belgium michel.delforge@uzleuven.be.
  • Minuk L; London Health Sciences Centre, London, ON, Canada.
  • Eisenmann JC; Hôpital Emile Muller, Mulhouse, France.
  • Arnulf B; Hôpital Saint-Louis, Paris, France.
  • Canepa L; Clinica Ematologica, A.O.U. San Martino di Genova, Italy.
  • Fragasso A; Unità Operativa di Oncoematologia, Ospedale di Matera, Italy.
  • Leyvraz S; Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
  • Langer C; Klinik für Innere Medizin III, Ulm, Germany.
  • Ezaydi Y; Royal Hallamshire Hospital, Sheffield, UK.
  • Vogl DT; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Giraldo-Castellano P; CIBER Enfermedades Raras (CIBERER), Translational Research Unit, Miguel Servet University Hospital, Zaragoza, Spain.
  • Yoon SS; Seoul National University Hospital, Korea.
  • Zarnitsky C; Rhumatologie Nord, Hôpital J. Monod, Le Havre, France.
  • Escoffre-Barbe M; CHRU Hôpital de Pontchaillou, Rennes, France.
  • Lemieux B; CHUM Hôpital Notre-Dame, Montreal, QUE, Canada.
  • Song K; Vancouver General Hospital, Vancouver, BC, Canada.
  • Bahlis NJ; Tom Baker Cancer Centre - University of Calgary, Calgary, AL, Canada.
  • Guo S; Evidera, Lexington, MA, USA.
  • Monzini MS; Celgene Corporation, Summit, NJ, USA.
  • Ervin-Haynes A; Celgene Corporation, Summit, NJ, USA.
  • Houck V; Celgene Corporation, Summit, NJ, USA.
  • Facon T; Hôpital Claude Huriez, Lille, France.
Haematologica ; 100(6): 826-33, 2015 Jun.
Article en En | MEDLINE | ID: mdl-25769541
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Protocolos de Quimioterapia Combinada Antineoplásica / Estado de Salud / Mieloma Múltiple Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Protocolos de Quimioterapia Combinada Antineoplásica / Estado de Salud / Mieloma Múltiple Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Año: 2015 Tipo del documento: Article